Neuropsychiatric Drug Development Summit 2018
Hanson Wade
30.07.2018 - 01.08.2018
Courtyard Boston Cambridge
777 Memorial Drive
Cambridge, 02139 Boston
USA
Conference themes
Globally it's estimated 1 in 5 people suffer from neuropsychiatric disorders. This figure, combined with drugs that are showing little or no response is making neuropsychiatric disorders a huge unmet clinical need.
The neuropsychiatric drug development field has been stifled for decades by a lack of scientific progress in understanding the brain and costly and challenging clinical trials.
Notes
Speakers: Jim Cassella, Niels Plath, Janet Nicholson, Brigitte Robertson, Mickey Matsumoto, Srinivas Rao, Mark Smith, Christopher Missling, Venkatesha Murthy, Eva Kohegyi
"Going International promotes access to education and training for all regardless of social, geographic and national borders."